![Jeffrey Ludwig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Ludwig
Inga fler pågående positioner
Förmögenhet: 773 832 $ per 2026-06-30
Profil
Jeffrey Ludwig worked at Amgen, Inc. from 2001 to 2019, serving as Vice President-Oncology Sales from 2014 to 2019.
Then worked at Astellas Pharma, Inc. from 2019 to 2020 as Vice President-Oncology Sales.
Education includes an undergraduate degree from Arizona State University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC. 0,19 % | 2026-04-13 | 95 417 ( 0,19 % ) | 773 832 $ | 2026-06-30 |
Tidigare kända positioner av Jeffrey Ludwig
| Företag | Position | Slut |
|---|---|---|
| PUMA BIOTECHNOLOGY, INC. | Företagsledare/Principal | 2025-05-08 |
| ASTELLAS PHARMA INC. | Företagsledare/Principal | 2020-03-01 |
| AMGEN INC. | Företagsledare/Principal | 2019-08-01 |
Jeffrey Ludwigs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
76
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma, Inc.
 Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
Puma Biotechnology, Inc.
 Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer | Health Technology |
